Andere talen Haemonetics Corporation

Aandelen

HAE

US4050241003

Beurs gesloten - Nyse Andere beurzen 22:00:02 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
90,99 ^USD	+3,80%		+12,00%	+6,41%

04/04	Haemonetics krijgt goedkeuring van FDA voor nieuwe TEG 6s Global Hemostasis-HN cartridge	MT
04/04	Haemonetics Corporation ontvangt goedkeuring van FDA voor nieuwe TEG®? 6s Global Hemostasis - HN Cartridge	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024	10/04
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge	05/04
Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge	04/04
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge	04/04
Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge	04/04
Haemonetics Corporation Completes Acquisition of Attune Medical	01/04
Haemonetics Corporation completed the acquisition of Advanced Cooling Therapy, Inc.	01/04
Haemonetics to Acquire Attune Medical for $160 Million	05/03
Haemonetics Announces Definitive Agreement to Acquire Attune Medical	05/03
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference	21/02
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day	21/02
Haemonetics Q3 Adjusted Earnings, Revenue Increase; Shares Rise	08/02
North American Morning Briefing : S&P 500 to Open -2-	08/02
Haemonetics: Fiscal Q3 Earnings Snapshot	08/02
Haemonetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023	08/02
Haemonetics Corporation Updates Revenue Guidance for the Fiscal Year 2024	08/02
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website	08/02
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024	11/01
Haemonetics Completes $255 Million Acquisition of OpSens	12/12
OpSens Brief: NYSE's Haemonetics Completed Acquisition	12/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Haemonetics Corporation

Aandelen

HAE

US4050241003

Andere talen

Filters